Home/Subscribe/Services
  • Home Page
  • Subscribe to Psychopharmacology Bulletin on-line
  • CME on demand: Independent CME for Practitioners
  • Editorial Advisory Board
  • Author's Guidelines
  • Brief Bulletins from the Field, V. 41, N. 2, 2008
  •  
  • RECENT SUBMISSIONS TO PSYCHOPHARMACOLOGY BULLETIN
  • Psychopharmacology Bulletin: Fast Facts
Enduring Materials: Indexed by Category
  • Original Research
  • Drug Disposition & Pharmacokinetics
  • Evidence-Based Medicine
  • Complicated Case Histories
  • —  Negative & Failed Clinical Trial Reports
  • General Psychiatry
  • Translational Neuroscience
  • Brain Imaging
  • Psychiatric Comorbidities
  • Review Articles
  • Letters to the Editor
Enduring Materials: Miscellaneous
  • Scientific Reprints
  • Assessment & Diagnostic Rating Scales
  • Scientific Articles & Editorials
  • Articles from our Spanish Journal
  • Clinical Reference Guides: Tools you can use
  • Patient/Physician Resource Guides
News of the Day
  • FDA Warns About Naltrexone Injection Site
  • Na'l Academy: anthrax vaccine ups psych illness
  • Study: Physical Fitness = Less Alzheimer's Disease
  • AstraZeneca Submits Seroquel XR in Europe for MDD
  • FDA Approves Vyvanse for Use in Adults
  • Abilify Receives Expanded Indications
  • Outcomes to Measure Clinical Trials in Children
  • Stimulant Improves Sleep in Adults With ADHD
  • New Link: Down's Syndrome and Alzheimer's Disease
  • Vagal Nerve Stimulation for Depression
  • Pristiq, Wyeth Antidepressant, Approved by FDA
  • Antidepressants for the Treatment of Chronic Pain
  • FDA Accepts NDA of Milnacipran for Fibromyalgia
  • Assessing Suicide Risk in Bipolar Patients
  • Metformin Effective in Antipsychotic Weight Gain
  • Double Relapse Rates for Pregnant Bipolar Patients
General Information
  • MedWorks' Other Titles
  •  
  • Contact Us
  • Editor's Login
Search Engine
  • Useful Links
    • MedWorks Media
    • Medscape WebMD CME
    • National Library of Medicine
    • Medline/Pubmed
    • Centerwatch Clinical Trials
    • FDA Website Index
    • APA Calendar
    • Bioethics Web Log
    • NIMH Home Page
    • health4care
    • In the Pipeline
    • The Carlat Psychiatry Blog
    • Furious Seasons
  • Of  Interest
    • Economics of Scientific and Biomedical Journals
    • Psychiatry Best Evidence Powered by McMaster Plus

brainscienceblogs.com

New Medicine Brought to Life by the World's Top Researchers

Negative & Failed Clinical Trial Reports

An Open-Label Study of Tiagabine in Panic Disorder
By David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD,and Juris Janavs, MD

Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
By Gahan J. Pandina, PhD, Carla M. Canuso, MD, Ibrahim Turkoz, MS, Mary Kujawa, MD, PhD,
and Ramy A. Mahmoud, MD, MPH

Posted on Tuesday, March 25, 2008 at 02:45PM by Registered CommenterContacts in Negative & Failed Clinical Trial Reports | CommentsPost a Comment
Copyright © 2008, MedWorks Media Global. All rights reserved.